Levi & Korsinsky is investigating the Board of Directors of Alcon Inc. (“Alcon” or the “Company”) (NYSE: ACL) for possible breaches of fiduciary duty.
New York, NY, January 15, 2010 — Levi & Korsinsky is investigating the Board of Directors of Alcon Inc. (“Alcon” or the “Company”) (NYSE: ACL) for possible breaches of fiduciary duty and other violations of state law arising out of the announcement by Novartis AG (“Novartis”) (NYSE: NVS) that it has exercised its right to acquire Nestle S.A.’s (“Nestle”) stake in Alcon for $180 per share in cash, or a total of $28.1 billion, giving it an overall ownership interest in Alcon of approximately 77%, and its intent to pay 2.8 of its own shares for each remaining Alcon share held by the public, equivalent to about $11.2 billion. The investigation concerns whether the Alcon Board of Directors breached their fiduciary duties to Alcon shareholders and whether the Alcon minority shareholders are being harmed as a result of the proposed transaction.
If you own common stock in Alcon and wish to obtain additional information, please contact us at the number listed below or visit http://www.zlk.com/acl1.html.
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.
CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street – 15th Floor, New York, NY 10004, Tel: (212) 363-7500, Fax: (212) 363-7171, www.zlk.com
Press Release Distribution By PressReleasePoint
Press Contact:
Joseph Levi
Levi & Korsinsky, LLP
New York, NY
212-363-7500
[email protected]
